Recombinant Human CD5 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 1636-CD
Key Product Details
Source
NS0
Accession #
Structure / Form
Monomer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human CD5 protein
Arg25-Asn371, with a C-terminal 10-His tag
Arg25-Asn371, with a C-terminal 10-His tag
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Arg25
Predicted Molecular Mass
39.9 kDa
SDS-PAGE
55 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Zymosan is coated at 200 μg/mL (100 μL/well), the concentration of Recombinant Human CD5 that produces 50% optimal binding response is typically 0.6-3 μg/mL.
When Zymosan is coated at 200 μg/mL (100 μL/well), the concentration of Recombinant Human CD5 that produces 50% optimal binding response is typically 0.6-3 μg/mL.
Formulation, Preparation and Storage
1636-CD
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: CD5
References
- Soldevila, G. et al. (2011) Curr. Opin. Immunol. 23:310.
- Jones, N.H. et al. (1986) Nature 323:346.
- Calvo, J. et al. (1999) Tissue Antigens 54:128.
- Brown, M.H. and E. Lacey (2010) J. Immunol. 185:6068.
- Van de Velde, H. et al. (1991) Nature 351:662.
- Vera, J. et al. (2009) Proc. Natl. Acad. Sci. 106:1506.
- Azzam, H.S. et al. (1998) J. Exp. Med. 188:2301.
- Hawiger, D. et al. (2004) Immunity 20:695.
- Tarakhovsky, A. et al. (1995) Science 269:535.
- Friedlein, G. et al. (2007) J. Immunol. 178:6821.
- Ordonez-Rueda, D. et al. (2009) Eur. J. Immunol. 39:2233.
- de Wit, J. et al. (2011) Blood 118:6107.
- Bikah, G. et al. (1996) Science 274:1906.
- Hippen, K.L. et al. (2000) J. Exp. Med. 191:883.
- Yanaba, K. et al. (2008) Immunity 28:639.
- Gary-Gouy, H. et al. (2002) Blood 100:4537.
- Renaudineau, Y. et al. (2005) Blood 106:2781.
- Sarhan, M.A. et al. (2012) J. Virol. Epub.
Alternate Names
CD5
Gene Symbol
CD5
UniProt
Additional CD5 Products
Product Documents for Recombinant Human CD5 Protein, CF
Product Specific Notices for Recombinant Human CD5 Protein, CF
For research use only
Loading...
Loading...
Loading...
Loading...